A specific amyloid-beta protein assembly in the brain impairs memory

This paper has been retracted. The record we hold marks it as a retracted publication. Check the original source below for the retraction notice before relying on anything it reports.

Topic: Disease mechanisms in lab and animal studies

Memory function often declines with age, and is believed to deteriorate initially because of changes in synaptic function rather than loss of neurons. Some individuals then go on to develop Alzheimer's disease with neurodegeneration. Here we use Tg2576 mice, which express a human amyloid-beta precursor protein (APP) variant linked to Alzheimer's disease, to investigate the cause of memory decline in the absence of neurodegeneration or amyloid-beta protein amyloidosis. Young Tg2576 mice (< 6 months old) have normal memory and lack neuropathology, middle-aged mice (6-14 months old) develop memory deficits without neuronal loss, and old mice (> 14 months old) form abundant neuritic plaques containing amyloid-beta (refs 3-6). We found that memory deficits in middle-aged Tg2576 mice are caused by the extracellular accumulation of a 56-kDa soluble amyloid-beta assembly, which we term Abeta*56 (Abeta star 56). Abeta*56 purified from the brains of impaired Tg2576 mice disrupts memory when administered to young rats. We propose that Abeta*56 impairs memory independently of plaques or neuronal loss, and may contribute to cognitive deficits associated with Alzheimer's disease.

Key findings

• We found that memory deficits in middle-aged Tg2576 mice are caused by the extracellular accumulation of a 56-kDa soluble amyloid-beta assembly, which we term Abeta*56 (Abeta star 56).
• We propose that Abeta*56 impairs memory independently of plaques or neuronal loss, and may contribute to cognitive deficits associated with Alzheimer's disease.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1038/nature04533
• PubMed: 16541076
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{lesne2006-16541076,
  author  = {Lesné, S. and Koh, M. T. and Kotilinek, L. and Kayed, R. and Glabe, C. G. and Yang, A. and Gallagher, M. and Ashe, K. H.},
  title   = {{A specific amyloid-beta protein assembly in the brain impairs memory}},
  journal = {Nature},
  year    = {2006},
  doi     = {10.1038/nature04533},
  pmid    = {16541076},
  url     = {https://doi.org/10.1038/nature04533}
}

Related studies in Brain tissue and pathology

• Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene Nature genetics · 1992-06-01 · usefulness score 58/100
• Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior Behavioural brain research · 2008-02-17 · usefulness score 36/100
• Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline JAMA · 2000-03-01 · usefulness score 59/100
• Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation Nature medicine · 2005-03-20 · usefulness score 52/100
• Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease Brain pathology (Zurich, Switzerland) · 2008-04-01 · usefulness score 48/100
• Beta-amyloid, blood vessels, and brain function Stroke · 2009-05-14 · usefulness score 47/100

Also tagged “presenilin”

343 studies in the library carry the topic tag “presenilin”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 343 tagged studies.

• Neurodegenerative disease: amyloid pores from pathogenic mutations Nature · 2002-07-01 · usefulness score 41/100 · Brain tissue and pathology
• Developing a Gene Therapy for the Treatment of Autosomal Dominant Alzheimer's Disease Human gene therapy · 2023-10 · usefulness score 41/100 · Risk genes beyond APOE
• Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2 Proceedings of the National Academy of Sciences of the United States of America · 2003-05-09 · usefulness score 36/100 · Risk genes beyond APOE

Similar studies

• Deciphering the molecular basis of memory failure in Alzheimer's disease 2004 · Disease mechanisms
• Oligomerization of Alzheimer's β-Amyloid within Processes and Synapses of Cultured Neurons and Brain 2004 · Disease mechanisms
• Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 2001 · Risk genes beyond APOE
• Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models 1999 · Risk genes beyond APOE
• Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein 1999 · Biomarkers
• The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind 2017 · Treatments

More on Brain tissue and pathology

• A review that covers this ground Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies Progress in neurobiology · 2002-10-01 · usefulness score 50/100
• Newest in this subject Inflammatory biomarker candidates in dementia with Lewy bodies: diagnostic classification, clinical associations, and survival Research Square · 2026-11-01 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject TMEM106B C-Terminal fragment aggregation exacerbates α-synuclein and TDP-43 proteinopathy phenotypes bioRxiv · 2026-10-30 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Brain tissue and pathology →